Participated · Equity · Feb 2026

Founded in 2018, Lower Austria–based Aviloo has developed a hardware-, software- and analytics-driven system that delivers an objective assessment of an EV battery’s health in about three minutes and is compatible with more than 96 % of electric vehicles. The company serves over 750 customers across more than 30 countries, including dealer networks, fleet operators, leasing firms, testing societies and OEMs such as Hyundai and Mercedes-Benz. Its solution has become a de-facto standard for transparent battery certification, supporting a market that is expected to grow rapidly as the global EV fleet triples by 2030. Aviloo reports annual revenue growth of more than 100 % and is already active in Europe, Asia, Australia and the United States. The newly secured capital will fund accelerated international expansion—particularly in the U.S. and Asia—and fuel multiple product launches slated for 2026. Strategic leadership remains with CEO Marcus Berger and founders Nikolaus Mayerhofer and Wolfgang Berger, who retain significant ownership stakes. Investors believe the company’s resilient business model and clear technological differentiation position it well for global scale.

Led · Series A · Nov 2023

HeartBeat.bio is a Vienna-based biotech developing a human organoid cultivation, screening and AI-supported data analysis solution for cardiac drug development. Its cardioid drug discovery platform relies on self-assembling, highly reproducible cardiac organoids that recapitulate human physiology and enable modeling of heart diseases not achieved with other in-vitro systems. The company is currently focused on drug-induced and various subtypes of genetic cardiomyopathies, with additional programs planned in diabetic cardiomyopathy, myocardial infarction and cardiac remodeling/fibrosis. Led by CEO Michael Krebs, HeartBeat.bio intends to use the funds to complete its cardioid platform for proprietary and collaborative drug discovery programs. Financially, the company closed a €4.5M Pre-Series A round. The platform combines organoid biology and AI-enabled data analysis to accelerate development of therapeutics for heart failure and related indications. HeartBeat.bio is a Vienna, Austria-based spin-off of the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) developing a high-throughput 3D screening platform for heart diseases using self-organizing human cardiac organoids called Cardioids. The Cardioid technology, invented by the Mendjan lab at IMBA, enables automated, reproducible, and cost-effective large-scale generation and analysis of cardiac organoids suitable for high-throughput compound screening. The company intends to use the €1.5m seed financing to establish operations, build an experienced team over the next 12 months, and develop Cardioid into a platform solution for compound screening. Its drug discovery program will focus on heart failure, cardiomyopathies, and cardiotoxicity studies for new drug candidates. HeartBeat.bio has signed an exclusive license and collaboration agreement with IMBA and will closely cooperate with Sasha Mendjan's research group to further develop the technology. The company has also received financial support from AWS via the AWS Pre-Seed Program and from Vienna's INiTS AplusB Scaleup Program.

Participated · Series D · May 2021

IVI is a Moscow-based video-on-demand platform targeting Russian-speaking viewers, offering licensed content and live-streaming channels for independent producers. Founded in 2010 by Oleg Tumanov, the company positions itself as a national streaming champion. Management says the new capital will be used to expand the platform’s content catalogue and to foster the creation of original programming. IVI emphasizes creating monetization opportunities for content producers and continuing to enhance service and user experience. The company has raised $434.7 million to date in equity and debt financing. ivi is one of Russia's largest OTT video-on-demand platforms. The company says it holds 42% of Russia’s licensed professional OTT VOD market, about twice the share of the second-largest player. Revenues reached approximately $63 million in 2018. ivi's core product is an on-demand streaming service serving Russian viewers. The company plans to use new capital to further accelerate growth and solidify its market-leading position, particularly by expanding its own content production. In support of those plans, ivi secured a $40 million funding round from a group of investors. Ivi.ru is an online streaming service that offers premium TV, feature and documentary films, cartoons and music videos licensed from major Hollywood studios, music majors, and European and Russian producers. The company says its catalog exceeds 65,000 titles. It reports more than 10 million monthly unique users watching over 50 million videos across its website and mobile apps, up from about 3 million visitors a year earlier. Ivi plans to use new funding to build out its technology and expand its content catalog, improve user experience, and extend distribution to multiple mobile platforms and smart TVs. Management says Russia is the primary market, with possible future expansion into adjacent former Soviet markets under consideration. The service faces competition from YouTube and Rutube and potential entrants such as Hulu and Netflix as Russian broadband adoption grows.

Participated · Series A · Feb 2017

Knotel leases buildings, takes a small office for its staff, and outfits spaces with modular furniture so companies can move in and operate private, fully furnished workspaces. Unlike traditional coworking operators, Knotel focuses on enterprise clients rather than shared freelancer spaces. The company has internal tech products — Baya, a blockchain platform for data-driven acquisition decisions, and Geometry, a subscription furnishing service — intended to reduce costs and accelerate growth. Knotel now manages more than 4 million square feet across over 200 locations in cities including New York, San Francisco, London, Los Angeles, Washington, D.C., Paris, Berlin, Toronto, Boston, São Paulo and Rio de Janeiro; its London footprint stands at 263,000 square feet across 63 locations. The company plans to expand into the world’s 30 largest cities, add roughly a dozen more cities, and deepen engagement with global enterprise accounts to grow with capital efficiency. In less than four years it has raised a total of $560 million, is valued at more than $1 billion, and will use the new financing to grow its footprint and continue rapid global expansion. Knotel designs and manages agile office space for established and growing companies. Founded in 2016 by Amol Sarva, the company is NYC-based and operates nearly 100 locations in New York, San Francisco, London and Berlin. Its member network includes companies such as Starbucks, Netflix and Daimler. Knotel targets mid-market and enterprise customers. The company intends to use new funding to deepen coverage in current core and new markets among those segments. As of the reported round, total funding to date was $160M. Knotel designs and runs bespoke flexible office locations as an alternative to long-term leases and traditional coworking, offering customization in look, feel, and operations. The company focuses on providing agility for established and growing brands, allowing clients to evolve their footprints without sacrificing customization. In two years it opened forty locations across New York, San Francisco, and London, totaling nearly 1 million square feet. Today over 200 companies call Knotel home, including Starbucks, Stash, and King. Knotel plans to use new funding to more than double in size and deepen coverage in core and new markets among mid-market and enterprise businesses. The company was founded in 2016. Knotel, founded in 2015, provides a "headquarters as a service" product that lets companies customize office space while growing or shrinking as needed. The company emphasizes it is distinct from coworking, positioning its spaces as company-specific, culture-coded environments. Knotel operates a managed marketplace that connects tenants and property owners rather than buying large amounts of real estate itself. It currently runs 10 locations in New York City and raised $25M in a Series A to fund expansion. The company plans to add 40 locations over the next year, with New York as its immediate focus, and targets startups as well as media, television, finance and other non-tech tenants. Knotel says its model shares earnings with property owners—giving owners most of the earnings while Knotel retains a margin—to keep both parties viable in down markets.